Average Co-Inventor Count = 6.36
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Aprinoia Therapeutics Limited (3 from 6 patents)
3. Ares Trading S.a. (1 from 135 patents)
4. Tocopherx, Inc. (1 from 1 patent)
18 patents:
1. 12116364 - Heteroaryl compounds and uses thereof
2. 11655216 - Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
3. 11642413 - Compounds for degrading Tau protein aggregates and uses thereof
4. 11291732 - Compounds for degrading α-synuclein aggregates and uses thereof
5. 11046714 - 2,2-difluorodioxolo Areceptor antagonists
6. 10961215 - N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
7. 10941152 - Pyrazole compounds as modulators of FSHR and uses thereof
8. 10894775 - Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
9. 10822338 - Substituted aminoquinazoline compounds as Aantagonist
10. 10208055 - Pyrazole compounds as modulators of FSHR and uses thereof
11. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
12. 9688654 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
13. 9676780 - [object Object]
14. 9493440 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
15. 9416126 - Compounds inhibiting leucine-rich repeat kinase enzyme activity